With this hands-on introduction readers will learn what SDEs are all about and how they should use them in practice.

The track detector conference was held under the joint auspices of the Parliamentary Assembly of the Council of Europe and the University of Bristol. This proceedings volume contains over 160 papers which cover the latest developments and applications of solid state nuclear track detectors in medicine, physics, chemistry, space research, geology and other fields.

Solid State Nuclear Track Detectors is a collection of papers that covers various aspects of solid state nuclear track detectors. The book presents 130 articles that cover the concerns in the mechanisms, operations, and applications of solid state nuclear track detectors. The materials in the text are thematically grouped into three parts. The book first discusses the fundamental mechanisms, which include determination of the screening parameter from measurements of differential energy loss and atomic displacement effects from heavy ion induced coulomb explosion. Next, the selection presents articles that deal with the methodology of detectors, such as experimental track widths of low energy heavy ions in nuclear emulsion and structure of light nuclei tracks. The remaining papers cover the fields of applications, such as nuclear fusion; prospection of radioactive and fissionable minerals; dosimetry; and autoradiography. The book will be of great use to researchers and practitioners of disciplines related to nuclear science.

The decay product of the medical isotope molybdenum-99 (Mo-99), technetium-99m (Tc-99m), and associated medical isotopes iodine-131 (I-131) and xenon-133 (Xe-133) are used worldwide for medical diagnostic imaging or therapy. The United States consumes about half of the world's supply of Mo-99, but there has been no domestic (i.e., U.S.-based) production of this isotope since the late 1980s. The United States imports Mo-99 for domestic use from Australia, Canada, Europe, and South Africa. Mo-99 and Tc-99m cannot be stockpiled for use because of their short half-lives. Consequently, they must be routinely produced and delivered to medical imaging centers. Almost all Mo-99 for medical use is produced by irradiating highly enriched uranium (HEU) targets in research reactors, several of which are over 50 years old and are approaching the end of their operating lives. Unanticipated and extended shutdowns of some of these old reactors have resulted in severe Mo-99 supply shortages in the United States and other countries. Some of these shortages have disrupted the delivery of medical care. Molybdenum-99 for Medical Imaging examines the production and utilization of Mo-99 and associated medical isotopes, and provides recommendations for medical use.